[Retracted] Efficacy of Etimicin Sulfate Combined with Cefotaxime Sodium in the Treatment of Patients with Septic Shock and Effect on Serum Inflammatory Factor Levels and Immune Function

Table 1

Comparison of baseline data between the two groups ((mean ± SD), (case, %)).

Indicator	Control group (n = 44)	Research group (n = 51)	value
Age (years)	51.87 ± 8.23	52.13 ± 7.95	0.876
Admission length (days)	10.25 ± 2.01	10.33 ± 1.97	0.845
Gender (male/female)	24/20	28/23	0.972
Infection sites
Pulmonary infection	24 (54.55)	27 (52.94)	0.876
Intraabdominal infection	11 (25.00)	13 (25.49)	0.956
Biliary infection	9 (20.45)	11 (21.57)	0.894
Underlying disease
Hypertension high blood pressure	18 (40.91)	21 (41.18)	0.979
Diabetes mellitus	10 (22.73)	12 (23.53)	0.926
Coronary heart disease	4 (9.09)	5 (9.80)	0.906